FDA issued a Warning Letter to Taro Pharmaceuticals, Inc on 2/5/2009 as a result of this inspection.
483 Taro Pharmaceuticals Jul 2008

483 Taro Pharmaceuticals Jul 2008

$119 - Not in Stock

FDA investigators audited the Taro Pharmaceuticals - Brampton, Canada facility and issued inspectional observations (via FDA 483) on 31 Jul 2008.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Jul 2008
  • Location: Brampton, Canada
  • FEI: 3002808384

Pre-Order Not Available